The Washington State Health Care Authority Health Technology Clinical Committee (HTCC) reviewed balloon angioplasty and stenting for lower extremity peripheral artery disease evidence Nov. 21. ACR® participated in the discussion along with the Society of Interventional Radiology, Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, and the Outpatient Endovascular and Interventional Society. ACR began monitoring this topic in August 2025.
HTCC issued draft findings and a coverage decision that are open for public comment until Dec. 16. The coverage determination is for Endovascular therapy for activity-limiting intermittent claudication and chronic limb-threatening ischemia as a covered benefit with conditions. ACR members who perform these procedures are encouraged to submit feedback. Email comments to shtap@hca.wa.gov.
Final findings and coverage decisions will be published in March. Meeting materials and presentations are on the HTCC website.
For more information or if you have questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.
ACR Leaders at World Health Expo
ACR leaders presented at WHX Dubai on global AI, quality and safety initiatives advancing high-quality imaging and safe AI adoption worldwide.
Read more
Cancer Screening Bills Advance in Early 2026 Sessions
States advance 2026 bills expanding breast and colorectal cancer screening coverage and reducing patient costāsharing.
Read moreAsk Legislators to Cosponsor Bill to Enforce No Surprises Act
ACR urges members to support bipartisan bills enforcing timely insurer payments under the No Surprises Act.
Read more